BCG Vaccination and Lung Immune Response
Author Information
Author(s): Kaveh Daryan, A. Bachy, Véronique S. Hewinson, R. Glyn Hogarth, Philip J.
Primary Institution: TB Research Group, Animal Health and Veterinary Laboratories Agency (AHVLA), Addlestone, Surrey, United Kingdom
Hypothesis
How does BCG vaccination confer immunity against tuberculosis?
Conclusion
BCG vaccination induces a long-lasting population of multifunctional CD4 T cells in the lungs that are associated with protection against tuberculosis.
Supporting Evidence
- A single systemic BCG vaccination induces distinct populations of T effector memory cells.
- These CD4+ T cells produce multiple cytokines and are maintained for over 16 months.
- Following mycobacterial challenge, these cells expand significantly in the lungs.
Takeaway
The BCG vaccine helps the body create special immune cells that can fight off tuberculosis for a long time, even after just one shot.
Methodology
Mice were immunized with BCG and then challenged with M. bovis; immune responses were measured in the spleen and lungs.
Potential Biases
Potential bias in interpreting immune responses based on animal models.
Limitations
The study was conducted in mice, which may not fully replicate human responses.
Participant Demographics
Female BALB/c mice, 8 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website